Grant Ocular Therapeutix, Inc Transaction History
Grant
- $201 Million
- Q3 2024
A detailed history of Grant transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Grant holds 47,691 shares of OCUL stock, worth $495,509. This represents 0.21% of its overall portfolio holdings.
Number of Shares
47,691
Previous 36,039
32.33%
Holding current value
$495,509
Previous $246,000
68.29%
% of portfolio
0.21%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding OCUL
# of Institutions
157Shares Held
139MCall Options Held
86.4KPut Options Held
263K-
Summer Road LLC West Palm Beach, FL14.9MShares$155 Million98.56% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$133 Million9.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$132 Million2.86% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.61MShares$89.5 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $800M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...